InnoCare Pharma launches IPO with cornerstone backing
Chinese biopharmaceutical firm InnoCare Pharma kicked off bookbuilding for its Hong Kong IPO on Wednesday, securing over half of the deal with cornerstone investors.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: